Literature DB >> 6866010

Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle.

M C Souroujon, D Mochly-Rosen, A S Gordon, S Fuchs.   

Abstract

Several monoclonal antibodies (mcAbs) elicited against the nicotinic acetylcholine receptor (AChR) from Torpedo react also with skeletal muscle AChR. Such mcAbs were used to define antigenic determinants on muscle AChR and to elucidate their effect on muscle AChR functions. Primary chick muscle cultures were used as a model for skeletal muscle. Of the four mcAbs studies only mcAb 5.5, which is directed against the cholinergic site in Torpedo AChR, blocks the binding of alpha-bungarotoxin (alpha-Bgt) to AChR in chick muscle cultures and inhibits carbamylcholine-induced sodium transport in these cells. The interaction of mcAb 5.5 with the cholinergic site on muscle AChR demonstrates the conservation of this site. Two mcAbs, 5.5 and 5.34, each of a different antigenic specificity but both directed against conformation-dependent antigenic determinants, accelerate the degradation of AChR in muscle cultures. From the reactivity of the various mcAbs with Triton-solubilized and membranous AChR it appears that there are some antigenic differences between the detergent solubilized and membranous forms of the receptor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866010     DOI: 10.1002/mus.880060410

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

Review 1.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Antibodies to synthetic peptides as probes for the binding site on the alpha subunit of the acetylcholine receptor.

Authors:  D Neumann; J M Gershoni; M Fridkin; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.

Authors:  D Barchan; M C Souroujon; S H Im; C Antozzi; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs.

Authors:  G Goldberg; D Mochly-Rosen; S Fuchs; Y Lass
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

5.  Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

Authors:  S H Im; D Barchan; S Fuchs; M C Souroujon
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library.

Authors:  M Balass; Y Heldman; S Cabilly; D Givol; E Katchalski-Katzir; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

7.  Analysis of acetylcholine receptor phosphorylation sites using antibodies to synthetic peptides and monoclonal antibodies.

Authors:  A Safran; D Neumann; S Fuchs
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

8.  Mapping of the cAMP-dependent phosphorylation sites on the acetylcholine receptor.

Authors:  M C Souroujon; D Neumann; S Pizzighella; M Fridkin; S Fuchs
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

9.  Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.

Authors:  A R Pachner
Journal:  Yale J Biol Med       Date:  1987 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.